Literature DB >> 23890420

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy.

Michael A Grassi1, Wanjie Sun2, Sapna Gangaputra3, Patricia A Cleary2, Larry Hubbard3, John M Lachin2, Xiaoyu Gao2, Szilárd Kiss4, Andrew J Barkmeier5, Arghavan Almony6, Matthew Davis3, Ronald Klein3, Ronald P Danis3.   

Abstract

PURPOSE: This study sought to determine the validity of self-report of prior panretinal photocoagulation (PRP) and focal photocoagulation (FP) compared with fundus photography.
DESIGN: Prospective cohort study. PARTICIPANTS: One thousand three hundred sixty-three type 1 diabetic subjects from the Epidemiology of Diabetes Interventions and Complications (EDIC) study, a subset of the 1441 subjects originally enrolled in the multicenter Diabetes Control and Complications Trial.
METHODS: At each annual visit, subjects were asked by EDIC staff whether they had undergone PRP, FP, or both since the last completed annual clinic visit. Fundus photographs were collected from one quarter of the cohort each year and from the entire cohort at EDIC years 4 and 10. Photographs were graded for the presence and extent of PRP and FP. Seventeen years of subject reporting and photograph grading of PRP and FP were compared in EDIC subjects. MAIN OUTCOME MEASURES: The κ, sensitivity, specificity, and positive and negative predictive values were calculated for subject-reported PRP and FP. Factors influencing subject misreporting were investigated.
RESULTS: For subject reporting, 1244 (96%) of 1296 subjects with gradable photographs accurately reported whether they had a history of PRP in one or both eyes, and 1259 (97.5%) of 1291 with valid photographs correctly reported their history of FP. For PRP and FP, sensitivities were 90.4% and 74.0%, respectively; specificities were 96.0% and 98.8%, respectively; positive predictive values were 75.9% and 80.3%, respectively; negative predictive values were 98.9% and 98.4%, respectively; and κ values were 0.80 and 0.76, respectively. Risk factors associated with misreporting included prior laser for diabetic retinopathy and prior ocular surgery (each P<0.04).
CONCLUSIONS: For subjects with type 1 diabetes, in the absence of a clinical examination or fundus photographs, subject self-report could be a reliable tool in a well-monitored study for assessing laser treatment type in diabetic retinopathy.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23890420      PMCID: PMC3818390          DOI: 10.1016/j.ophtha.2013.06.002

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study.

Authors:  Lauren Patty; Cathy Wu; Mina Torres; Stanley Azen; Rohit Varma
Journal:  Ophthalmology       Date:  2012-04-25       Impact factor: 12.079

2.  Genome-wide meta-analysis for severe diabetic retinopathy.

Authors:  Michael A Grassi; Anna Tikhomirov; Sudha Ramalingam; Jennifer E Below; Nancy J Cox; Dan L Nicolae
Journal:  Hum Mol Genet       Date:  2011-03-26       Impact factor: 6.150

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

Authors: 
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

5.  Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.

Authors:  Michael J Elman; Haijing Qin; Lloyd Paul Aiello; Roy W Beck; Neil M Bressler; Frederick L Ferris; Adam R Glassman; Raj K Maturi; Michele Melia
Journal:  Ophthalmology       Date:  2012-09-19       Impact factor: 12.079

6.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Neil M Bressler; Haijing Qin; Roy W Beck; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

Review 7.  Ranibizumab: in diabetic macular oedema.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

8.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

9.  Patient self-report of prior laser treatment reliably indicates presence of severe diabetic retinopathy.

Authors:  Michael A Grassi; D Anthony Mazzulla; Michael D Knudtson; Wendy W Huang; Kristine E Lee; Barbara E Klein; Dan L Nicolae; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2008-12-03       Impact factor: 5.258

10.  Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings.

Authors: 
Journal:  Ophthalmology       Date:  1978-01       Impact factor: 12.079

View more
  7 in total

1.  Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose.

Authors:  Lili Hu; Hongxia Yang; Ming Ai; Shuanghong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-14       Impact factor: 3.117

2.  ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.

Authors:  Petter Bjornstad; David M Maahs; Marian Rewers; Richard J Johnson; Janet K Snell-Bergeon
Journal:  J Diabetes Complications       Date:  2014-07-04       Impact factor: 2.852

3.  Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study.

Authors:  Petter Bjornstad; David M Maahs; Christopher J Rivard; Laura Pyle; Marian Rewers; Richard J Johnson; Janet K Snell-Bergeon
Journal:  Acta Diabetol       Date:  2014-06-15       Impact factor: 4.280

4.  Intensive diabetes therapy and ocular surgery in type 1 diabetes.

Authors:  Lloyd Paul Aiello; Wanjie Sun; Arup Das; Sapna Gangaputra; Szilard Kiss; Ronald Klein; Patricia A Cleary; John M Lachin; David M Nathan
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

5.  Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study.

Authors:  Petter Bjornstad; David M Maahs; Lindsey M Duca; Laura Pyle; Marian Rewers; Richard J Johnson; Janet K Snell-Bergeon
Journal:  J Diabetes Complications       Date:  2016-02-11       Impact factor: 2.852

6.  Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes.

Authors:  Andrew D Skol; Segun C Jung; Ana Marija Sokovic; Siquan Chen; Sarah Fazal; Olukayode Sosina; Poulami P Borkar; Amy Lin; Maria Sverdlov; Dingcai Cao; Anand Swaroop; Ionut Bebu; Barbara E Stranger; Michael A Grassi
Journal:  Elife       Date:  2020-11-09       Impact factor: 8.140

7.  The role of sirt1 in the retinal ganglion cells cultured by high glucose.

Authors:  Yue Zhou; Lian-Jun Cai; Li-Hui Xu; Yu Guo; Nuo Chen; Qing Yao
Journal:  Int Ophthalmol       Date:  2020-11-11       Impact factor: 2.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.